Mayo Clinic Center for Clinical and Translational Science (CCaTS)
梅奥诊所临床和转化科学中心 (CCaTS)
基本信息
- 批准号:10632337
- 负责人:
- 金额:$ 781.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-18 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateCOVID-19COVID-19 pandemicCaringClinicClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCommunitiesCompetenceCountryEducationElementsEnvironmentEventFacultyFoundationsFundingGoalsHealthHealth systemHealthcareHumanIncubatorsIndividualInformaticsInstitutionInterdisciplinary StudyInvestmentsJusticeKnowledgeLeadershipLearningMedical StudentsMethodologyMethodsMinnesotaMissionNational Center for Advancing Translational SciencesPatient CarePatientsPersonsPopulationPositioning AttributeProcessResearchResearch PersonnelResourcesRoleRural PopulationScientistSecureStructural RacismTalentsTechnologyTrainingTraining and EducationTranslational ResearchTranslationsTrustUnited States National Institutes of HealthVisionWorkbaseclinical centerclinical practicedigitaldigital healthdiversity and equitygraduate studenthealth care service organizationhealth disparityhealth equityhealth equity promotionhealth inequalitiesimprovedinnovationinterestmedical schoolsmembermultidisciplinarynoveloperationpandemic diseaseprogramsresponsescience educationsocial disparitiessynergismtheoriestoolunderserved community
项目摘要
Contact PD/PI: Lucchinetti, Claudia F.
OVERALL: Project Summary/Abstract
Mayo Clinic is one of the largest not‐for‐profit, academic health systems, top-ranked for quality more often than
any other health care organization. It has integrated operations in 5 U.S. states, and more than 1 million people
came to Mayo Clinic for care last year. Clinical and translational science (CTS) is a fundamental and highly
valued element of Mayo Clinic; indeed, all research at Mayo Clinic is directed towards translation of scientific
knowledge to improve patient care, with almost 60% of our NIH funding base classified as clinical research or
trials. In recognition of the importance of continued advances in CTS to the Mayo Clinic mission, our
institutional leadership has entrusted the Mayo Clinic Center for Clinical and Translational Sciences (CCaTS)
to be the engine of translational innovation and the institutional advocate for CTS and translational research.
CCaTS has served as a CTS innovation incubator for numerous efforts that were created with CCaTS funding
and are now supported by the institution. The overall vision of CCaTS is to enable high-quality, team-based
multidisciplinary research that accelerates clinical trial innovation, facilitates digital health transformation, and
partners with our stakeholders and communities to improve patient care and health for all people. Our team-
based culture has been described as one of “boundarylessness,” wherein organizational barriers are removed
to enable talent, innovation, and knowledge to converge where needed. In this context and that of our
longstanding commitment to patient-focused research, we are uniquely positioned to accomplish the following
Specific Aims. In Aim 1, we will simplify and accelerate the work of translation to improve health for all by
advancing clinical trial innovations and digital health transformations, streamlining methods and processes,
and developing novel informatics solutions that increase efficiency and drive implementation of discoveries that
improve health and promote health equity. In Aim 2, we will enhance our education programs through the
expanded reach of competency-based, learner-focused solutions, training a diverse, inclusive, multidisciplinary
CTS workforce to be prepared to address the urgent health care needs of all communities in a rapidly changing
environment. In Aim 3, we will engage local community members and patients to be active partners in
translational teams, expanding research capabilities of underserved communities, including rural populations.
Our goal is to improve health and reduce health inequities by helping these communities realize the benefits of
CTS. In Aim 4, we will expand national and regional partnerships and strengthen collaborative CTS networks
in all aspects of CTS and education, focusing on sharing innovative approaches and prioritizing diversity,
equity, and inclusion, with the goal of improving human health and advancing health equity. In summary,
sustained investment in CCaTS will enable us to continue to meet ongoing and emergent challenges in health
care for all, as exemplified by our response to support communities through the COVID-19 crisis.
Project Summary/Abstract Page 289
Contact PD/PI: Lucchinetti, Claudia F.
联系人 PD/PI:Lucchinetti、Claudia F.
总体而言:项目摘要/摘要
梅奥诊所是最大的非营利性学术医疗系统之一,在质量方面经常排名第一
它在美国 5 个州拥有超过 100 万人的综合业务。
去年来到梅奥诊所接受护理的临床和转化科学(CTS)是一门基础性的、高度重视的学科。
梅奥诊所的重要元素;事实上,梅奥诊所的所有研究都旨在转化科学成果
NIH 近 60% 的资金基础被归类为临床研究或
认识到 CTS 的持续进步对 Mayo Clinic 使命的重要性,我们
机构领导委托梅奥诊所临床和转化科学中心 (CCaTS)
成为转化创新的引擎以及 CTS 和转化研究的机构倡导者。
CCaTS 已成为 CTS 创新孵化器,为 CCaTS 资金创建的众多项目提供服务
现在得到了该机构的支持,CCaTS 的总体愿景是实现高质量、基于团队的目标。
多学科研究加速临床试验创新,促进数字健康转型,以及
与我们的利益相关者和社区合作,改善患者护理和所有人的健康。
基于文化被描述为“无边界”文化之一,但组织障碍已被消除
使人才、创新和知识在这种背景下和我们的背景下汇聚起来。
长期致力于以患者为中心的研究,我们具有独特的优势来实现以下目标
具体目标 在目标 1 中,我们将简化并加速翻译工作,以改善所有人的健康。
推进临床试验创新和数字健康转型,简化方法和流程,
开发新颖的信息学解决方案,提高效率并推动发现的实施
在目标 2 中,我们将通过以下方式加强我们的教育计划:
扩大基于能力、以学习者为中心的解决方案的范围,培训多元化、包容性、多学科的人才
CTS 员工队伍将做好准备,在快速变化的形势下满足所有社区的紧急医疗保健需求
在目标 3 中,我们将让当地社区成员和患者成为积极的合作伙伴。
转化团队,扩大服务欠缺社区(包括农村人口)的研究能力。
我们的目标是通过帮助这些社区实现以下各项的好处来改善健康并减少健康不平等
CTS。在目标 4 中,我们将扩大国家和区域伙伴关系并加强 CTS 协作网络。
在 CTS 和教育的各个方面,重点是分享创新方法并优先考虑多样性,
公平和包容,以改善人类健康和促进健康公平为目标。
对 CCaTS 的持续投资将使我们能够继续应对健康领域持续存在和紧急的挑战
关爱所有人,我们为支持社区渡过 COVID-19 危机而采取的应对措施就是例证。
项目摘要/摘要第 289 页
联系人 PD/PI:Lucchinetti、Claudia F.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VESNA D GAROVIC其他文献
VESNA D GAROVIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VESNA D GAROVIC', 18)}}的其他基金
2021 Physiology in Focus: The Role of Sex Hormones, Genetics and Gender in Physiology & Medicine
2021 年生理学焦点:性激素、遗传学和性别在生理学中的作用
- 批准号:
10319292 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
The KAPP-Sen Tissue Mapping Center Collaborative
KAPP-森组织绘图中心合作
- 批准号:
10376627 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
The KAPP-Sen Tissue Mapping Center Collaborative
KAPP-森组织绘图中心合作
- 批准号:
10701907 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
Hypertensive pregnancy disorders and future coronary artery disease
妊娠高血压疾病和未来冠状动脉疾病
- 批准号:
10452767 - 财政年份:2018
- 资助金额:
$ 781.85万 - 项目类别:
Hypertensive pregnancy disorders and future coronary artery disease
妊娠高血压疾病和未来冠状动脉疾病
- 批准号:
10188609 - 财政年份:2018
- 资助金额:
$ 781.85万 - 项目类别:
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
梅奥诊所临床和转化科学中心 (CCaTS)
- 批准号:
10674614 - 财政年份:2017
- 资助金额:
$ 781.85万 - 项目类别:
VEGF Signaling in Endothelial and Glomerular Epithelial Cells in Preeclampsia
先兆子痫中内皮细胞和肾小球上皮细胞中的 VEGF 信号转导
- 批准号:
7846807 - 财政年份:2008
- 资助金额:
$ 781.85万 - 项目类别:
VEGF Signaling in Endothelial and Glomerular Epithelial Cells in Preeclampsia
先兆子痫中内皮细胞和肾小球上皮细胞中的 VEGF 信号转导
- 批准号:
8051634 - 财政年份:2008
- 资助金额:
$ 781.85万 - 项目类别:
相似海外基金
Access to medical care and health care utilization among low-income immigrants
低收入移民获得医疗保健的机会和医疗保健利用
- 批准号:
10789176 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别:
The effect of HOusing instability and neighborhood deprivation on Maternal hEalth-HOME
住房不稳定和邻里剥夺对孕产妇健康的影响-HOME
- 批准号:
10756017 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别:
2023 Cellular and Molecular Mechanisms of Toxicity Gordon Research Conference and Seminar
2023细胞和分子毒性机制戈登研究会议暨研讨会
- 批准号:
10672627 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别:
A Translational Research Approach to Healthy Technology Usage in Language-Minority Families with Young Children
有幼儿的语言少数群体家庭健康技术使用的转化研究方法
- 批准号:
10822222 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别: